192 related articles for article (PubMed ID: 29570823)
21. Improvement of Sclerodermatous Graft-Versus-Host Disease in Mice by Niclosamide.
Morin F; Kavian N; Nicco C; Cerles O; Chéreau C; Batteux F
J Invest Dermatol; 2016 Nov; 136(11):2158-2167. PubMed ID: 27424318
[TBL] [Abstract][Full Text] [Related]
22. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy.
McCarthy KL; Playford EG; Looke DF; Whitby M
Clin Infect Dis; 2007 Mar; 44(5):e55-6. PubMed ID: 17278050
[TBL] [Abstract][Full Text] [Related]
23. Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia.
Neoh CF; Snell GI; Levvey B; Kotsimbos T; Morrissey O; Slavin MA; Stewart K; Kong DC
Med J Aust; 2014 Nov; 201(9):543-4. PubMed ID: 25358582
[No Abstract] [Full Text] [Related]
24. Case of ultraviolet B-mediated photosensitivity during the administration of voriconazole.
Mizuno S; Itoh M; Matsuo H; Kikuchi S; Asahina A
J Dermatol; 2019 Sep; 46(9):e327-e328. PubMed ID: 31021004
[No Abstract] [Full Text] [Related]
25. A Pediatric Case of Sclerodermatous Graft-Versus-Host Disease Responsive to Ultraviolet A1 Phototherapy.
Lazzeri L; Tripo L; Pescitelli L; Ricceri F; Prignano F
Pediatr Dermatol; 2016; 33(2):e99-102. PubMed ID: 26871550
[TBL] [Abstract][Full Text] [Related]
26. Methotrexate ultraviolet reactivation reaction in the setting of voriconazole-induced phototoxicity.
Holahan HM; Ferguson NN; Farah RS; Liu V
Int J Dermatol; 2015 Nov; 54(11):e496-7. PubMed ID: 26267431
[No Abstract] [Full Text] [Related]
27. Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD).
Gmeinhart B; Hinterberger W; Greinix HT; Rabitsch W; Kirnbauer R; Reiter E; Volc-Platzer B
Bone Marrow Transplant; 1999 Jun; 23(11):1197-9. PubMed ID: 10382961
[TBL] [Abstract][Full Text] [Related]
28. [Chronic sclerodermiform graft versus host disease (GvHD)].
Müller-Serten B; Vakilzadeh F
Hautarzt; 1994 Nov; 45(11):772-5. PubMed ID: 7822202
[TBL] [Abstract][Full Text] [Related]
29. Gingival squamous cell carcinoma in a patient with chronic graft-versus-host disease.
Otsubo H; Yokoe H; Miya T; Atsuta F; Miura N; Tanzawa H; Sato K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Aug; 84(2):171-4. PubMed ID: 9269019
[TBL] [Abstract][Full Text] [Related]
30. Voriconazole photosensitivity causes apparent graft-versus-host disease exacerbation.
Mukherjee A; Ekinci E; Scholoff A; Obi G; Vu N; Carrum G; Kamble RT
Bone Marrow Transplant; 2019 Feb; 54(2):323-325. PubMed ID: 30087464
[No Abstract] [Full Text] [Related]
31. Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease.
Bisaccia E; Palangio M; Gonzalez J
Transfus Apher Sci; 2011 Oct; 45(2):187-90. PubMed ID: 21890415
[TBL] [Abstract][Full Text] [Related]
32. 5% fluorouracil chemowraps in the management of widespread lower leg solar keratoses and squamous cell carcinoma.
Tallon B; Turnbull N
Australas J Dermatol; 2013 Nov; 54(4):313-6. PubMed ID: 23651243
[TBL] [Abstract][Full Text] [Related]
33. Nonmelanoma skin cancer in childhood after hematopoietic stem cell transplant: a report of 4 cases.
Rork JF; Margossian SP; Nambudiri VE; Huang JT
J Pediatr Hematol Oncol; 2014 Apr; 36(3):224-7. PubMed ID: 23619124
[TBL] [Abstract][Full Text] [Related]
34. Voriconazole and squamous cell carcinoma after lung transplantation: A multicenter study.
Hamandi B; Fegbeutel C; Silveira FP; Verschuuren EA; Younus M; Mo J; Yan J; Ussetti P; Chin-Hong PV; Solé A; Holmes-Liew CL; Billaud EM; Grossi PA; Manuel O; Levine DJ; Barbers RG; Hadjiliadis D; Aram J; Singer LG; Husain S
Am J Transplant; 2018 Jan; 18(1):113-124. PubMed ID: 28898527
[TBL] [Abstract][Full Text] [Related]
35. Topical treatment of field cancerization.
Ulrich C
Cancer Treat Res; 2009; 146():439-46. PubMed ID: 19415223
[No Abstract] [Full Text] [Related]
36. Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey.
Lem J; Younus M; Aram JA; Moosavi S; Freivogel K; Lewis A; Sobel RE
Pharmaceut Med; 2019 Apr; 33(2):121-133. PubMed ID: 31933256
[TBL] [Abstract][Full Text] [Related]
37. Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation.
Kuklinski LF; Li S; Karagas MR; Weng WK; Kwong BY
J Am Acad Dermatol; 2017 Oct; 77(4):706-712. PubMed ID: 28780363
[TBL] [Abstract][Full Text] [Related]
38. Cervical and vaginal cancer in a woman with chronic graft-versus-host disease.
Bolla D; Ruhstaller T; Diener PA; Lang F; Hornung R
Int J Gynaecol Obstet; 2011 Aug; 114(2):159-60. PubMed ID: 21669422
[No Abstract] [Full Text] [Related]
39. Association of CYP2C19 *17/*17 Genotype With the Risk of Voriconazole-Associated Squamous Cell Carcinoma.
Williams K; Arron ST
JAMA Dermatol; 2016 Jun; 152(6):719-20. PubMed ID: 26982740
[No Abstract] [Full Text] [Related]
40. Sclerodermatous Chronic Graft-versus-Host Disease Treated With Imatinib: A Dermatological Perspective.
Molés-Poveda P; Montesinos P; Sanz-Caballer J; de Unamuno B; Piñana JL; Sahuquillo A; Botella-Estrada R
Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):241-247. PubMed ID: 29254596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
